Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study (Q33562586)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study |
scientific article |
Statements
1 reference
Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study (English)
1 reference
Petros P Sfikakis
1 reference
Vlassis Grigoropoulos
1 reference
Ioannis Emfietzoglou
1 reference
George Theodossiadis
1 reference
Nicholas Tentolouris
1 reference
Evi Delicha
1 reference
Kleopatra Alexiadou
1 reference
Erifili Hatziagelaki
1 reference
Panayiotis G Theodossiadis
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference